Document Detail


Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
MedLine Citation:
PMID:  19778769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this study was to assess prosthesis/annulus discongruence and its impact on the occurrence of significant aortic regurgitation (AR) immediately after transcatheter aortic valve implantation (TAVI).
BACKGROUND: Paravalvular AR might occur after TAVI, but its determinants remain unclear.
METHODS: Comprehensive echocardiographic examinations were performed in 74 patients who underwent TAVI with a balloon expandable device. Congruence between annulus and device was appraised with the cover index: 100 x (prosthesis diameter - transesophageal echocardiography annulus diameter)/prosthesis diameter.
RESULTS: At baseline aortic valve area was 0.67 +/- 0.2 cm(2), and mean gradient was 50 +/- 15 mm Hg. The TAVI used transfemoral approach in 46 patients (62%) and transapical access in 28 (38%). Prosthesis size was 23 mm in 24 patients (34%) and 26 mm in 50 patients (66%). After TAVI, paravalvular AR was absent in 5 patients (7%), graded 1/4 in 53 (72%), 2/4 in 12 (16%), and 3/4 in 4 (5%). Occurrence of AR >or=2/4 was related to greater patient height, larger annulus, and smaller cover index (all p < 0.002) but not to ejection fraction, severity of stenosis, or prosthesis size. AR >or=2/4 was never observed in patients with aortic annulus <22 mm or with a cover index >8%. Significant improvements were observed from the first 20 cases (AR >or=2/4, 40%) to the last 54 (AR >or=2/4, 15%) (p = 0.02). In multivariate analysis, independent predictors of AR >/=2/4 were low cover index (odds ratio: 1.22; per confidence interval: 1.03 to 1.51 per 1% decrease, p = 0.02) and first versus last procedures (odds ratio: 2.24; 95% confidence interval: 1.07 to 5.22, p = 0.03).
CONCLUSIONS: Our study shows that the occurrence of AR >or=2/4 is related to prosthesis/annulus discongruence even after adjustment for experience. Hence, to minimize paravalvular AR, appropriate annular measurements and prosthesis sizing are critical.
Authors:
Delphine Détaint; Laurent Lepage; Dominique Himbert; Eric Brochet; David Messika-Zeitoun; Bernard Iung; Alec Vahanian
Related Documents :
22700259 - High-intensity focused ultrasound treatment of liver tumours: post-treatment mri correl...
15450569 - Ascending aortic origin of a branch pulmonary artery--surgical management and long-term...
16408469 - Vacuum-assisted closure system for the treatment of mediastinitis after total aortic ar...
17689749 - Usefulness of doppler echocardiography guidance during balloon aortic valvuloplasty for...
8950259 - The ross procedure in children.
9079249 - Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis.
2391989 - Tcm treatment of retinal vein occlusion in 216 cases.
23681209 - Percutaneous versus surgical closure of atrial septal defects in children and adolescents.
23089199 - Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  JACC. Cardiovascular interventions     Volume:  2     ISSN:  1876-7605     ISO Abbreviation:  JACC Cardiovasc Interv     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-25     Completed Date:  2009-12-03     Revised Date:  2014-09-05    
Medline Journal Info:
Nlm Unique ID:  101467004     Medline TA:  JACC Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  821-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aortic Valve Insufficiency / etiology*,  prevention & control,  ultrasonography
Aortic Valve Stenosis / surgery*,  ultrasonography
Cardiac Catheterization* / adverse effects,  instrumentation
Catheterization* / adverse effects,  instrumentation
Clinical Competence
Echocardiography, Transesophageal
Female
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation* / adverse effects,  instrumentation
Humans
Male
Odds Ratio
Prosthesis Design
Risk Assessment
Risk Factors
Severity of Illness Index
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedur...
Next Document:  Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograd...